We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 130

Antitrust, competition and economic regulation client quarterly newsletter
  • Hogan Lovells
  • China, European Union, Greece, USA
  • January 24 2012

A public company CEO recently consented to a federal district court order requiring him to pay a $500,000 civil penalty for violating the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”


Antitrust and competition - the EU weekly briefing (14 March 2016)
  • Winston & Strawn LLP
  • Denmark, European Union, France, Greece, United Kingdom
  • March 14 2016

Commission approves McKesson acquisition of UDG Healthcare in the EEA but refers UK element to the CMA for approval. On 4 March 2016


The General Court of the EU overturns the two European Commission lignite decisions
  • Hogan Lovells
  • Greece, European Union
  • October 31 2012

In two landmark rulings on 20 September 2012, the General Court of the European Union in Luxembourg annulled the two European Commission decisions on the Greek “lignite” case


European Court provides preliminary ruling on the legality of OPAP's monopoly
  • Olswang LLP
  • European Union, Greece
  • January 25 2013

On 24 January 2013, the Court of Justice of the European Union handed down a preliminary judgment on questions referred to it by the Greek courts in


Parallel trade in medicines: ECJ judgment in the second reference re: GlaxoSmithKline’s supply policy in Greece and abuse of dominant position
  • Bird & Bird
  • European Union, Greece
  • October 16 2008

In the second reference to the European Court of Justice arising out of GSK’s policy of selling medicines directly to Greek hospitals and pharmacies the ECJ has held (Joined Cases C-46806 to C-47806 Sot. Lelos kai Sia and Others) that an undertaking which occupies a dominant position on the relevant market for medicinal products is abusing its dominant position contrary to Article 82 EC if, in order to stop parallel exports, it refuses to meet “ordinary orders” from wholesalers


ECJ rules in major pharmaceuticals case
  • Squire Patton Boggs
  • European Union, Greece
  • October 30 2008

The European Court of Justice (ECJ) has issued a preliminary ruling in the dispute over supply quotas imposed by GlaxoSmithKline (GSK) on prescription drug wholesalers in Greece


European high court decision delivers blow to Greek gambling monopoly
  • Duane Morris LLP
  • European Union, Greece
  • January 29 2013

This past Friday, the Court of Justice of the European Union, the EU's highest court, issued an opinion finding that national legislation granting an


ECJ rules on award criteria in Greek case
  • Nabarro LLP
  • European Union, Greece
  • February 27 2008

Following a preliminary reference from a Greek Court, the European Court of Justice (ECJ) gave its ruling (in case C-53206) on questions raised concerning award criteria used in the assessment of a contract to carry out parts of a town planning project for the Municipality of Alexandrouplois


ECJ delivers long-awaited judgment in Glaxo ‘Greek’ Case on parallel imports
  • Hogan Lovells
  • European Union, Greece
  • September 22 2008

On September 16, 2008, the European Court of Justice (ECJ) handed down a long-awaited judgment in Sot Lélos kai Sia EE and Others v. GlaxoSmithKline AEVE Farmakeftikon Proïonton1 (the Greek Glaxo Case


Refusal to meet ordinary orders may amount to an abuse
  • Nabarro LLP
  • European Union, Greece
  • September 25 2008

On 16 September 2008, the European Court of Justice gave a ruling (in joined cases C-46806 C-47806) on questions referred by a Greek court, concerning whether the failure of a company to meet the orders of a wholesaler may amount to an abuse of a dominant position